Physician

Allen L. Yeilding, MD

According to 2025 Medicare claims, Allen Yeilding, MD (NPI: 1164443792) practices hematology/oncology in the Birmingham, AL market, with the plurality of this provider's patient population coming from Jefferson, AL. This provider's primary affiliated billing organization is HEMATOLOGY AND ONCOLOGY ASSOCIATES OF ALABAMA, LLC (NPI: 1134232770; TIN: 631137578) and primary practice location at 35209-6862.

Yeilding's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 380 traditional Medicare patients, billed 69,772 HCPCS/CPT codes, and received $1,874,129 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,560 prescription claims across 379 beneficiaries totaling $5,459,934 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 11 claims. Open Payments data shows 256 records totaling $5,991. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,333,601 to $1,874,129. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,151,097 to $5,459,934. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $7,538 and ending at $2,789.